Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia
- PMID: 26747825
- PMCID: PMC4787606
- DOI: 10.1093/cid/civ1214
Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia
Abstract
Background: The frequent lack of a microbiological diagnosis in community-acquired pneumonia (CAP) impairs pathogen-directed antimicrobial therapy. This study assessed the use of comprehensive multibacterial, multiviral molecular testing, including quantification, in adults hospitalized with CAP.
Methods: Clinical and laboratory data were collected for 323 adults with radiologically-confirmed CAP admitted to 2 UK tertiary care hospitals. Sputum (96%) or endotracheal aspirate (4%) specimens were cultured as per routine practice and also tested with fast multiplex real-time polymerase-chain reaction (PCR) assays for 26 respiratory bacteria and viruses. Bacterial loads were also calculated for 8 bacterial pathogens. Appropriate pathogen-directed therapy was retrospectively assessed using national guidelines adapted for local antimicrobial susceptibility patterns.
Results: Comprehensive molecular testing of single lower respiratory tract (LRT) specimens achieved pathogen detection in 87% of CAP patients compared with 39% with culture-based methods. Haemophilus influenzae and Streptococcus pneumoniae were the main agents detected, along with a wide variety of typical and atypical pathogens. Viruses were present in 30% of cases; 82% of these were codetections with bacteria. Most (85%) patients had received antimicrobials in the 72 hours before admission. Of these, 78% had a bacterial pathogen detected by PCR but only 32% were culture-positive (P < .0001). Molecular testing had the potential to enable de-escalation in number and/or spectrum of antimicrobials in 77% of patients.
Conclusions: Comprehensive molecular testing significantly improves pathogen detection in CAP, particularly in antimicrobial-exposed patients, and requires only a single LRT specimen. It also has the potential to enable early de-escalation from broad-spectrum empirical antimicrobials to pathogen-directed therapy.
Keywords: PCR; bacterial load; community-acquired pneumonia; molecular testing; viral.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America.
Comment in
-
Editorial Commentary: Quantitative Molecular Approach to Diagnosing Pneumonia.Clin Infect Dis. 2016 Apr 1;62(7):824-5. doi: 10.1093/cid/civ1216. Epub 2016 Jan 7. Clin Infect Dis. 2016. PMID: 26747824 No abstract available.
-
Editorial Commentary: The Modern Quest for the "Holy Grail" of Pneumonia Etiology.Clin Infect Dis. 2016 Apr 1;62(7):826-8. doi: 10.1093/cid/civ1219. Epub 2016 Jan 7. Clin Infect Dis. 2016. PMID: 26747826 Free PMC article. No abstract available.
-
Reply to Zelyas and Robinson.Clin Infect Dis. 2016 Jul 1;63(1):142-3. doi: 10.1093/cid/ciw206. Epub 2016 Apr 10. Clin Infect Dis. 2016. PMID: 27069065 No abstract available.
-
Finding the Pathogen in Community-acquired Pneumonia.Clin Infect Dis. 2016 Jul 1;63(1):142. doi: 10.1093/cid/ciw204. Epub 2016 Apr 10. Clin Infect Dis. 2016. PMID: 27069067 No abstract available.
References
-
- Lim WS, Baudouin SV, George RC et al. . BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64:iii1–55. - PubMed
-
- Jokinen C, Heiskanen L, Juvonen H et al. . Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol 1993; 137:977–88. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous